Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (5): 928-932. doi: 10.19723/j.issn.1671-167X.2021.05.019

Previous Articles     Next Articles

Clinical and pathological features of renal cell carcinoma with urinary tract tumor thrombus: 6 cases report and literature review

TIAN Yu1,CHENG Xiao-yue2,HE Hui-ying3,WANG Guo-liang1,(),MA Lu-lin1   

  1. 1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
    3. Department of Pathology, Peking University Third Hospital, Beijing 100191, China
  • Received:2021-04-06 Online:2021-10-18 Published:2021-10-11
  • Contact: Guo-liang WANG E-mail:wangguoliang@medmail.com.cn

Abstract:

Objective: To investigate the clinical characteristics, diagnosis and treatment of renal cell carcinoma with urinary tract tumor thrombus. Methods: From January 1, 2015 to December 31, 2019, patients with renal cell carcinoma complicated with urinary tract tumor thrombus who were hospitalized in the Peking University Third Hospital and Beijing Friendship Hospital, Capital Medical University were retrospectively analyzed. Meanwhile, we reviewed the literature, and the reported patients of renal cell carcinoma with urinary tract tumor thrombus were also included in our study. The basic information, clinical manifestations, treatment, pathological characteristics and follow-ups of all the patients were analyzed. Results: In our study, 6 patients from the two hospitals and 16 patients from previous literature reports were included. There were 13 males and 9 females with an average age of 54.7 years (22-79 years). Fifteen patients had renal cell carcinoma on the left side, 6 on the right side, and 1 on the unknown side. Gross hematuria was the most common chief complaint, including 18 patients. One patient complained of weight loss, 1 patient complained of microscopic hematuria, and 1 patient was found by ultrasound examination. Tumor thrombus was classified as grade Ⅰ in 9 cases (the tumor embolus protruded into the renal pelvis, but did not reach the ureteropelvic junction), grade Ⅱ in 10 cases (the tumor embolus protruded into the ureter, but not into the bladder), and grade Ⅲ in 3 cases (the tumor embolus passed through the ureter and protruded into the bladder). Only 11 patients were diagnosed with renal cell carcinoma before operation. Radical nephrectomy was performed in 9 cases and nephroureterectomy in 12 cases. In pathological diagnosis, there were 15 cases of clear cell renal cell carcinoma, 1 case of papillary renal cell carcinoma, 1 case of chromophobe cell carcinoma, 1 case of mixed cell renal cell carcinoma, 4 cases of renal cell carcinoma with undetermined classification. Eleven patients were followed up for 3-31 months, and 3 patients had lung metastasis within 6 months. Conclusion: Renal cell carcinoma with urinary tract tumor thrombus is rare in clinic. It needs to be differentiated from renal pelvis carcinoma in diagnosis. The treatment principle can refer to general renal carcinoma. For locally advanced cases, complete resection is the best treatment, and its oncological prognosis needs more long-term and large-scale follow-up observation.

Key words: Renal Cell Carcinoma, Urinary tract tumor thrombus, Neoplasm invasiveness

CLC Number: 

  • R737.11

Table 1

Clinical and pathological information of patients with renal cell carcinoma complicated with urinary tract tumor thrombus*"

Case Gender Age/
years
Chief
complaint
Tumor
thrombus
classification
Preoperative
diagnosis
Operation
method
Histological
diagnosis
WHO/ISUP
grade
Follow-up
1 Male 53 Gross
hematuria
Right RCC Open right radical
nephrectomy
Clear cell RCC No recurrence or
metastasis for 16 months
2 Female 50 Weight loss Left RCC Laparoscopic left
radical nephrectomy
Clear cell RCC No recurrence or
metastasis for 20 months
3 Male 70 Gross
hematuria
Right RCC/RPC Laparoscopic right
nephroureterectomy
RCC NA No recurrence or
metastasis for 31 months
4 Male 64 Gross
hematuria
Left RCC Laparoscopic left
radical nephrectomy
Clear cell RCC Ⅱ-Ⅲ Bilateral pulmonary nodules
before operation and
survival after 16 months
5 Male 63 Gross
hematuria
Left RPC Laparoscopic left
nephroureterectomy
Clear cell RCC No recurrence or
metastasis for 24 months
6 Male 61 Gross
hematuria
Right RCC Laparoscopic right
radical nephrectomy
Clear cell RCC Lung metastasis after
6 months and
survival after 18 months
7[1] Male 22 Right abdominal
pain with gross
hematuria
Right RPC Right
nephroureterectomy
Mixed RCC NA NA
8[2] Female 62 NA RPC NA RCC NA NA
9[3] Male 67 Gross
hematuria
Left RPC,
bladder tumor
Cystoscopy biopsy;
Open left
nephroureterectomy
Clear cell RCC NA
10[4] Male 43 Gross
hematuria
Left RCC Laparoscopic left
nephroureterectomy
Clear cell RCC Ⅱ-Ⅲ NA
11[5] Male 64 Gross
hematuria
Left RCC, right
adrenal metastasis
Laparoscopic left
radical nephrectomy
and right
adrenalectomy
Clear cell RCC NA
12[5] Female 77 Gross
hematuria
Right RCC Laparoscopic right
radical nephrectomy
Clear cell RCC NA
13[6] Female 58 Ultrasound
examination
Left RPC Laparoscopic left
nephroureterectomy
Clear cell RCC NA NA
14[7] Female 51 microscopic
hematuria
Left RPC Left nephroureterectomy Clear cell RCC Ⅰ-Ⅱ Lung metastasis
after 6 months
15[8] Male 51 Right back
pain with
gross hematuria
Right RCC Right ureteroscopy biopsy;
Open right radical
nephrectomy
RCC NA No recurrence or
metastasis for 9 months
16[9] Female 47 Gross
hematuria
Left RCC Open left
nephroureterectomy
Chromophobe
RCC
NA NA
17[10] Female 63 Gross
hematuria
Left RCC Left radical
nephrectomy
Clear cell RCC NA NA
18[11] Female 27 Gross
hematuria
Left RPC Open left
nephroureterectomy
RCC No recurrence or
metastasis for 3 months
19[12] Male 66 Gross
hematuria
Left RPC Open left
nephroureterectomy
Clear cell RCC NA Lung metastasis
after 5 months
20[13] Female 39 Left back pain
with gross
hematuria
Left RPC Left nephroureterectomy Clear cell RCC NA
21[14] Male 79 Gross hematuria Left RCC Robot-assisted laparoscopy
left radical nephrectomy
Clear cell RCC NA
22[15] Male 27 Gross hematuria Right RPC Laparoscopic right
nephroureterectomy
Papillary RCC,
type Ⅰ
NA No recurrence or
metastasis for 6 months

Figure 1

CT of 6 patients (cortical phase): the lesions showed inhomogeneous enhancement in cortical phase in Case 1, 2, 4, and 6, the enhancement degree was lower than that in renal parenchyma in Case 3 and 5"

Figure 2

Right nephroureterectomy specimen of Case 3 Figure 3 Histopathology of Case 3 3A, tumors prominent in the pelvis, HE ×20; 3B, HE ×100."

[1] Munechika H, Kushihashi T, Gokan T, et al. A renal cell carcinoma extending into the renal pelvis simulating transitional cell carcinoma [J]. Urol Radiol, 1990, 12(1):11-14.
pmid: 2333668
[2] Chen WC, Lee YH, Huang JK. Renal cell carcinoma with renal pelvic extension simulating transitional cell carcinoma: a case report [J]. Zhonghua Yi Xue Za Zhi, 1996, 58(2):147-150.
[3] Gulati M, Gore JL, Pantuek AJ, et al. Ureteral tumor thrombus from renal cell carcinoma extending into bladder [J]. Urol Oncol, 2007, 25(5):393-395.
doi: 10.1016/j.urolonc.2007.01.011
[4] Fujita O, Wada K, Yamasaki T, et al. Renal cell carcinoma with a tumor thrombus in the ureter: a case report [J]. BMC Urol, 2011, 11(16):1-5.
doi: 10.1186/1471-2490-11-1
[5] Kitazono MT, Coakley FV, Naeger DM, et al. CT of unusual renal masses invading the pelvicaliceal system: potential mimics of upper tract transitional cell carcinoma [J]. Clin Imaging, 2011, 35(1):77-80.
doi: 10.1016/j.clinimag.2010.02.012
[6] Jeong YB, Kim HJ. Is it transitional cell carcinoma or renal cell carcinoma on computed tomography image? [J]. Urology, 2012, 79(3):e42-e43.
doi: 10.1016/j.urology.2011.11.001
[7] Kakutani S, Kume H, Hirano Y, et al. Renal cell carcinoma with intraluminal spread of the entire upper urinary tract [J]. Case Rep Med, 2013, 2013:371387.
[8] Li Y, Ding YU, Chen D. Renal cell carcinoma growing into the renal pelvis and mimicking transitional cell carcinoma: A case report and literature review [J]. Oncol Lett, 2015, 9(4):1869-1872.
doi: 10.3892/ol.2015.2898
[9] 李嘉临, 纪志刚. 肾嫌色细胞癌侵入肾盂一例分析及文献复习 [J]. 国际外科学杂志, 2016, 43(9):625-627.
[10] Komatsubara M, Yamazaki M, Fujisaki A, et al. Tumor thrombus of renal cell carcinoma extending into the inferior vena cava, ova-rian vein, and ureter treated with neoadjuvant axitinib [J]. Urology, 2016, 95:e3-e4.
doi: 10.1016/j.urology.2016.05.057
[11] Parikesit D, Mochtar CA, Tanurahardja B, et al. Thrombus-like tumor of renal cell carcinoma mimicking transitional cell carcinoma of kidney: a case report [J]. Urol Case Rep, 2016, 10:26-29.
[12] Ishikawa T, Izumi K, Kondo T, et al. A case of renal cell carcinoma growing into the renal pelvis with a fibrin cap in the ureter and bladder [J]. Hinyokika Kiyo, 2018, 64(3):117-122.
doi: 10.14989/ActaUrolJap_64_3_117 pmid: 29684961
[13] Jeff J, Alessandro P. Clear cell renal cell carcinoma with a urete-ral thrombus [J]. J Endourol Case Rep, 2018, 4(1):159-162.
doi: 10.1089/cren.2018.0067 pmid: 30426074
[14] Bowman M, Reinstatler L, Pettus J, et al. An unusual case of renal cell carcinoma with tumor thrombosis of the proximal ureter [J]. Urol Case Rep, 2019, 23:60-61.
doi: 10.1016/j.eucr.2018.12.009 pmid: 30596019
[15] Kumar L, Jain S, Kaushal S, et al. A case of type 1 papillary renal cell cancer with pelvic tumor thrombus masquerading as urothelial cancer with review of literature [J]. J Endourol Case Rep, 2019, 5(4):157-160.
[16] Riehie JP. Carcinoma of the renal pelvis and ureter. Diagnosis and management of genitourinary cancer [M]. Philadelphia: Saunders, 1988: 323-336.
[17] National Cancer Institute. SEER Stat Fact Sheets: Kidney and renal pelvis cancer [EB/OL]. (2015-11-29) [2020-18-16]. http://seer.cancer.gov/statfacts/html/kidrp.html .
[18] 李松年. 中华影像医学: 泌尿生殖系统卷 [M]. 北京: 人民卫生出版社, 2002.
[19] Bata P, Tarnoki DL, Tarnoki AD, et al. Transitional cell and clear cell renal carcinoma: Differentiation of distinct histological types with multiphase CT [J]. Acta Radiol, 2014, 55(9):1112-1119.
doi: 10.1177/0284185113510493 pmid: 24243889
[20] Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual [M]. 8th ed. New York: Springer, 2017.
[1] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[2] YU Yan-fei,HE Shi-ming,WU Yu-cai,XIONG Sheng-wei,SHEN Qi,LI Yan-yan,YANG Feng,HE Qun,LI Xue-song. Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 640-646.
[3] XIAO Ruo-tao,LIU Cheng,XU Chu-xiao,HE Wei,MA Lu-lin. Prognostic value of preoperative platelet parameters in locally advanced renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 647-652.
[4] HONG Peng,TIAN Xiao-jun,ZHAO Xiao-yu,YANG Fei-long,LIU Zhuo,LU Min,ZHAO Lei,MA Lu-lin. Bilateral papillary renal cell carcinoma following kidney transplantation: A case report [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 811-813.
[5] HAN Song-chen,HUANG Zi-xiong,LIU Hui-xin,XU Tao. Renal functional compensation after unilateral radical nephrectomy of renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 680-685.
[6] ZHAO Xun,YAN Ye,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,ZHANG Hong-xian,LIU Cheng,MA Lu-lin. Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 665-670.
[7] Li-wei LI,Zhuo LIU,Guo-liang WANG,Hua ZHANG,Wen CHEN,Jing MA,Li ZHANG,Wei HE,Lu-lin MA,Shu-min WANG. Comparison of various imaging in the diagnosis of renal cell carcinoma with inferior vena cava tumor thrombus combined with bland thrombus [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 678-683.
[8] Qi TANG,Rong-cheng LIN,Lin YAO,Zheng ZHANG,Han HAO,Cui-jian ZHANG,Lin CAI,Xue-song LI,Zhi-song HE,Li-qun ZHOU. Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 628-631.
[9] Xiao-peng ZHANG,Zi-xiong HUANG,Lu-ping YU,Xiao-wei ZHANG,Qing LI,Shi-jun LIU,Tao XU. Clinical and pathological analysis of small renal cell carcinoma [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 623-627.
[10] HUANG Zi-xiong, DU Yi-qing, ZHANG Xiao-peng, LIU Shi-jun, XU Tao. Clinical and pathological analysis of renal cell carcinoma bone metastasis [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 811-815.
[11] DING Zhen-shan,QIU Min,XU Zi-cheng,XIAO Ruo-tao,GE Li-yuan,MA Lu-lin. Clinicopathological analysis of patients with papillary renal cell carcinoma complicated by tumor thrombus [J]. Journal of Peking University(Health Sciences), 2018, 50(5): 805-810.
[12] ZENG Hong, RONG Xiao-ying, ZHANG Xiao-qing, GUO Xiang-yang. Application of intraoperative cell salvage combined with leukocyte depletion filter on radical nephrectomy for renal carcinoma with inferior vena cava tumor thrombus:2 case reports#br# [J]. Journal of Peking University(Health Sciences), 2017, 49(4): 736-739.
[13] FANG Wei-gang, TIAN Xin-xia. Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP [J]. Journal of Peking University(Health Sciences), 2017, 49(2): 188-195.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .